Summary
The computed 12-month bankruptcy probability of LDM Pharma is 1.8% (moderate). The company has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. No annual accounts have been filed with the National Bank.
Acts, filings and financial milestones
2025
06-01
Gazette deed
IncorporationAppointment: Louis De Meyer (manager) · Pre-incorporation commitments · Founder9 facts ▸
Gazette deed
Incorporation
Appointment: Louis De Meyer (manager) · Pre-incorporation commitments · Founder9 facts ▸
- Pre-incorporation commitments, “takeover, alle verbintenissen aangegaan in naam en voor rekening van vennootschap in oprichting,alsmede alle verbintenissen en verplichtingen en rechten die daa…” (deed in Dutch)
- Other provision, “ldmpharma@outlook.be, Andere gegevens zoals gecommuniceerd naar Kruispuntbank van Ondernemingen” (deed in Dutch)
- Incorporation, 02-01-2025
- Founder, Louis De Meyer (general partner)
- Partner, Louis De Meyer (general partner)
- Capital
- Founding capital
- Director appointment, Louis De Meyer (manager (not named in the articles))
- Other provision, “geen statutaire zaakvoerders bij oprichting” (deed in Dutch)
Gazette deed
1 of 1 deed read